Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H31NO3 |
| Molecular Weight | 357.4864 |
| Optical Activity | ( - ) |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CC#CCOC(=O)[C@@](O)(C1CCCCC1)C2=CC=CC=C2
InChI
InChIKey=XIQVNETUBQGFHX-QFIPXVFZSA-N
InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3/t22-/m0/s1
| Molecular Formula | C22H31NO3 |
| Molecular Weight | 357.4864 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Preformulation studies on the S-isomer of oxybutynin hydrochloride, an Improved Chemical Entity (ICE). | 2001 Apr |
|
| [Non-coordinated micturition syndrome mimicking posterior urethral valves in a male neonate]. | 2003 Jul |
|
| Acupressure versus oxybutinin in the treatment of enuresis. | 2003 Nov-Dec |
|
| [Prevalence of urinary incontinence and linked factors in men and women over 65]. | 2003 Oct 15 |
|
| Oxybutynin extended-release: a review of its use in the management of overactive bladder. | 2004 |
|
| Drug approval highlights for 2003. | 2004 Feb |
|
| Rapid and selective UV spectrophotometric and RP-HPLC methods for dissolution studies of oxybutynin immediate-release and controlled-release formulations. | 2004 Nov 15 |
|
| A peripheric neuromodulation technique for curing detrusor overactivity: Stoller afferent neurostimulation. | 2005 |
|
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005 Jun |
|
| Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin. | 2007 Jul 13 |
|
| The neurogenic bladder: medical treatment. | 2008 May |
|
| Locked-in Syndrome in a Nigerian male with Multiple Sclerosis: a case report and literature review. | 2008 Oct 30 |
|
| Behavioral intervention versus pharmacotherapy or their combinations in the management of overactive bladder dysfunction. | 2009 |
|
| Oxybutynin extended release for the management of overactive bladder: a clinical review. | 2009 Sep 21 |
|
| Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation. | 2010 Jul |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:33:23 GMT 2023
by
admin
on
Sat Dec 16 19:33:23 GMT 2023
|
| Record UNII |
5BRQ29UUB7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5BRQ29UUB7
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY | |||
|
119618-21-2
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY | |||
|
300000045599
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY | |||
|
12152
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY | |||
|
6098167
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY | |||
|
C190351
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
RACEMATE -> ACTIVE ENANTIOMER |
|
||
|
TARGET -> INHIBITOR |
|
||
|
|
ENANTIOMER -> ENANTIOMER |
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
